Journal of International Obstetrics and Gynecology ›› 2023, Vol. 50 ›› Issue (3): 313-317.doi: 10.12280/gjfckx.20220743

• Research on Gynecological Malignancies: Case Report • Previous Articles     Next Articles

Cervical Inflammatory Myofibroblastic Tumor: A Case Report and Literature Review

MA Rui, ZHANG Xiang-xi, LI Jing-wen, CHEN Yu-huan, YANG Xiao-hong()   

  1. Jinzhou Medical University, Jinzhou 121000, Liaoning Province, China (MA Rui); Department of Gynecology, The Central Hospital of Xiaogan, Xiaogan 432100, Hubei Province, China (ZHANG Xiang-xi, LI Jing-wen, CHEN Yu-huan, YANG Xiao-hong)
  • Received:2022-09-15 Published:2023-06-15 Online:2023-06-27
  • Contact: YANG Xiao-hong, E-mail: y2851336@163.com

Abstract:

Cervical inflammatory myofibroblastic tumor (IMT) is a type of mesenchymal tumor with moderate malignant potential, unknown etiology, rare clinical manifestations, lack of specificity, its diagnosis depends on pathological morphology and immunohistochemical findings. One patient with cervical IMT was reported and the literature was reviewed to improve understanding of this tumor. The patient was admitted to the hospital due to the discovery of uterine fibroids for 5 years and irregular vaginal bleeding for more than half a month, and was clearly diagnosed as cervical IMT by segmented curettage+cervical biopsy before surgery, complete hysterectomy+bilateral adnexectomy+bilateral ovarian arteriovenous high ligation, and postoperative pathological examination confirmed the preoperative diagnosis. Laboratory tests and imaging examinations are not specific for cervical IMT, because it is similar to malignant tumors and not easy to identify, easily to misdiagnose and missed diagnosis, surgical resection is an effective treatment, it is recommended to completely resect the lesion, and complete hysterectomy, and regular follow-up after surgery.

Key words: Neoplasms, muscle tissue, Immunohistochemistry, Diagnosis, Therapy, Case reports